Safety, Tolerability, Pharmacokinetics of hzVSf-v13 in Healthy Adults (Intravenous and Subcutaneous Administration)

NCT04817202 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: hzVSF-v13 (intravenous, single dose)
DRUG: hzVSF-v13 (subcutaneous, single dose)
DRUG: hzVSF-v13 (intravenous, multiple dose)
DRUG: Placebo (intravenous, single dose)
DRUG: Placebo (subcutaneous, single dose)
DRUG: Placebo (intravenous, multiple dose)

Sponsor

ImmuneMed, Inc.